
First Trust Nasdaq Pharmaceuticals ETF
FTXH
Updated: 04/11/2026, 04:30:42
No historical data available
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
No summaries found.
- Share price
- $43.87
- Market cap
- $1.18B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 22/09/2016
- Beta
- 0.456
- Last dividend
- $0.00
- Day range
- $43.80 – $44.33
- 52-week range
- $29.85 – $44.78
- 1-day performance
- -0.04%
- 1-year performance
- 46.98%
- Current drawdown (1Y)
- -2.02%
- CIK
- 0001552740
- CUSIP
- 33738R837
- ISIN
- US33738R8372
- Created
- 07/12/2025, 04:08:03
- Last update
- 04/11/2026, 04:30:42
Track First Trust Nasdaq Pharmaceuticals ETF with an AI analyst
See which prediction-market events move FTXH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.